CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,452,539
+13.7%
155,224
+9.0%
0.00%0.0%
Q2 2023$2,156,193
+66.2%
142,417
+59.2%
0.00%
Q1 2023$1,297,431
+7.9%
89,478
+0.6%
0.00%
Q4 2022$1,202,874
-13.1%
88,970
+1.3%
0.00%
Q3 2022$1,385,000
+165.3%
87,859
+105.4%
0.00%
Q2 2022$522,000
-19.2%
42,782
-37.7%
0.00%
Q1 2022$646,000
-41.1%
68,704
+7.3%
0.00%
Q4 2021$1,097,00064,0190.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders